Absorption of recombinant human erythropoietin following subcutaneous injection in dialysis patients.

被引：0
|
作者：
Breen, CP
Marsden, J
James, GK
Chandler, G
Macdougall, IC
机构：
[1] Univ London Kings Coll Hosp, Dept Clin Biochem, KCSMD, London, England
[2] Univ London Kings Coll Hosp, Dept Dietet, KCSMD, London, England
[3] Univ London Kings Coll Hosp, Dept Renal Med, KCSMD, London, England
来源：
KIDNEY INTERNATIONAL | 1999年 / 55卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2561 / 2561
页数：1
相关论文
共 50 条
  • [41] RECOMBINANT-HUMAN-ERYTHROPOIETIN AND PERITONEAL-DIALYSIS
    DIGENIS, GE
    YATZIDIS, H
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1990, 13 (06): : 344 - 346
  • [42] Absorption of enteral recombinant human erythropoietin by neonates
    Juul, SE
    Christensen, RD
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (06) : 782 - 786
  • [43] ONCE WEEKLY VERSUS TWICE WEEKLY SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    LUI, SF
    LAW, CB
    TING, SM
    LI, P
    LAI, KN
    CLINICAL NEPHROLOGY, 1991, 36 (05) : 246 - 251
  • [44] DAILY SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHEPO) IN PERITONEAL-DIALYSIS PATIENTS - A EUROPEAN DOSE-RESPONSE STUDY
    FALLER, B
    SLINGENEYER, A
    WALLER, M
    MICHEL, C
    GRUTZMACHER, P
    MULLER, HP
    BARANY, P
    GRABENSEE, B
    ISSAD, B
    SCHMITT, H
    MEISL, F
    CLINICAL NEPHROLOGY, 1993, 40 (03) : 168 - 175
  • [45] Inflammation is a major determinant of erythropoietin resistance in dialysis patients.
    Gunnell, J
    Yeun, JY
    Depner, TA
    Kaysen, GA
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A1091 - A1091
  • [46] Darbepoetin alfa effectively maintains haemoglobin concentrations at extended dose intervals relative to intravenous or subcutaneous recombinant human erythropoietin in dialysis patients
    Brunkhorst, R
    Bommer, E
    Braun, J
    Haag-Weber, M
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (05) : 1224 - 1230
  • [47] SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN TO SUBJECTS ON CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS - AN ERYTHROKINETIC ASSESSMENT
    HUGHES, RT
    COTES, PM
    PIPPARD, MJ
    STEVENS, JM
    OLIVER, DO
    WINEARLS, CG
    ROYSTON, JP
    BRITISH JOURNAL OF HAEMATOLOGY, 1990, 75 (02) : 268 - 273
  • [48] SUBCUTANEOUS VERSUS INTRAVENOUS ADMINISTRATION OF HUMAN RECOMBINANT ERYTHROPOIETIN IN PATIENTS ON CHRONIC-HEMODIALYSIS
    BARNAS, U
    WATZINGER, U
    PEER, G
    MAYER, G
    GRAF, H
    NEFROLOGIA, 1990, 10 : 116 - 120
  • [49] SUBCUTANEOUS VERSUS INTRAVENOUS RECOMBINANT-HUMAN-ERYTHROPOIETIN ADMINISTRATION IN HEMODIALYSIS-PATIENTS
    BORAN, M
    DALVA, I
    YAZICIOGLU, A
    CETIN, S
    NEPHRON, 1993, 63 (01) : 113 - 114
  • [50] INTRAVENOUS VERSUS SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN PATIENTS ON HEMODIALYSIS AND CAPD
    EIDEMAK, I
    FRIEDBERG, MO
    LADEFOGED, SD
    LOKKEGAARD, H
    PEDERSEN, E
    SKIELBOE, M
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1992, 7 (06) : 526 - 529
12345